Efficacy and prognostic model development of immune checkpoint inhibitor rechallenge in recurrent or metastatic nasopharyngeal carcinoma: a real-world study
Yaofei Jiang, Jie Wu, Shuhui Dong, Zhenyu Zhang et autres
cn, sa (code pays fourni par la source)
2 citations
Cancer Immunology Immunotherapy